Therapeutic apheresis - Plasmapheresis

Clinical Medicine, Journal of the Royal College of Physicians of London

Volumn 6, Issue 4, 2006, Pages 343-347

  El Ghariani, Khaled ^a   Unsworth, David J ^b,c  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

^b NORTH BRISTOL NHS TRUST   (United Kingdom)

^c South West Centre ^*  (United Kingdom)

Author keywords

Autoantibody; Immunosuppression; Plasmapheresis; Vasculitis

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; FRESH FROZEN PLASMA; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE;

APHERESIS; AUTOIMMUNE DISEASE; BLOOD VISCOSITY; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL TRIAL; CRYOGLOBULINEMIA; GLOMERULONEPHRITIS; GLOMERULOSCLEROSIS; GUILLAIN BARRE SYNDROME; HUMAN; HYPERVISCOSITY SYNDROME; KIDNEY DISEASE; KIDNEY GRAFT REJECTION; LEUKAPHERESIS; METABOLIC DISORDER; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; NEUROLOGIC DISEASE; PARAPROTEINEMIA; PERIPHERAL NEUROPATHY; PLASMAPHERESIS; POLYCYTHEMIA; REVIEW; SICKLE CELL CRISIS; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT INDICATION;

EID: 33748071138     PISSN: 14702118     EISSN: None     Source Type: Journal    
DOI: 10.7861/clinmedicine.6-4-343     Document Type: Review

References (20)

1. Freedman J, Garvey MB. Immunoadsorption of factor VIII inhibitors. Review. Curr Opin Hematol 2004;11:327-33.
2. Smith JW, Weinstein R, for the AABB Hemapheresis Committee KL; AABB Hemapheresis Committee; American Society for Apheresis. Therapeutic apheresis: a summary of current indication categories endorsed by the AABB and the American Society for Apheresis. Transfusion 2003;43:820-2.
3. Cataland SR, Wu HM. Immunotherapy for thrombotic thrombocytopenic purpura. Curr Opin Hematol 2005;12:359-63.
4. Rock GA, Shumak KH, Buskard NA et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med 1991;325:393-7.
5. Coppo P, Bussel A, Charrier S et al. High-dose plasma infusion versus plasma exchange as early treatment of thrombotic thrombocytopenia purpura/hemolytic uremic syndrome. Medicine (Baltimore) 2003;82:27-38.
6. Winters JL, Pineda AA. New directions in plasma exchange. Curr Opin Hematol 2003;10:424-8.
7. Little MA, Pusey CD. Rapidly progressive glomerulonephritis: current and evolving treatment strategies. Review. J Nephrol 2004;17(Suppl 8):S10-9.
8. Johnson JP, Moore J Jr, Austin HA 3rd et al. Therapy of anti-glomerular basement membrane antibody disease: analysis of prognostic significance of clinical, pathologic, and treatment factors. Medicine (Baltimore) 1985;64:219-27.
9. Artero ML, Sharma R, Savin VJ, Vincenti F. Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis. Am J Kidney Dis 1994;23:574-81.
10. Pradhan M, Petro J, Palmer J, Meyers K, Baluarte HJ. Early use of plasmapheresis for recurrent post-transplant FSGS. Pediatr Nephrol 2003;18:934-8.
11. Hughes RA, Cornblath DR. Guillain-Barré syndrome. Review. Lancet 2005;366:1653-66.
12. Koller HK, Kieseier BC, Jander S, Hartung HP. Chronic inflammatory demyelinating polyneuropathy. Review. N Engl J Med 2005;352:1343-56.
13. Gloor JM, Lager DJ, Fidler ME et al. A comparison of splenectomy versus intensive posttransplant antidonor blood group antibody monitoring without splenectomy in ABO-incompatible kidney transplantation. Transplantation 2005;80:1572-7.
14. Ibernon M, Gil-Vernet S, Carrera M et al. Therapy with plasmapheresis and intravenous immunoglobulin for acute humoral rejection in kidney transplantation. Transplantation Proc 2005;37:3743-5.
15. Dyck PJ, Low PA, Windebank AJ et al. Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance. N Engl J Med 1991;325:1482-6.
16. Joint Task Force of EFNS and the PNS. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of paraproteinemic demyelinating neuropathies. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. J Periph Nerv Syst 2006;111:9-19.
17. Schilling S, Linker RA, Konig FB et al. Plasma exchange therapy for steroid-unresponsive multiple sclerosis relapses: clinical experience with 16 patients. Nervenartz 2006;77:430-8. [in German]
18. Thompson GR, Kitano Y. The role of low density lipoprotein apheresis in the treatment of familial hypercholesterolemia. Review. Ther Apher 1997;1:13-6.
19. Clark WF, Stewart AK, Rock GA et al. Plasma exchange when myeloma presents as acute renal failure: a randomized, controlled trial. Ann Intern Med 2005;143:777-84.
20. Lewis EJ, Hunsicker LG, Lan SP, Rohde RD, Lachin JM. A controlled trial of plasmapheresis in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group. N Engl J Med 1992;326:1373-9.